PD-1 and PD-L1 antibodies in cancer: current status and future directions.
- Published in:
- Cancer Immunology, Immunotherapy, 2017, v. 66, n. 5, p. 551, doi. 10.1007/s00262-017-1954-6
- By:
- Publication type:
- Article
Works matching IS 03407004 AND DT 2017 AND VI 66 AND IP 5
Results: 13
1
2
Differences in the frequencies of HLA-class I and II alleles between German patients with renal cell carcinoma and healthy controls.
- Published in:
- Cancer Immunology, Immunotherapy, 2017, v. 66, n. 5, p. 565, doi. 10.1007/s00262-017-1957-3
- By:
- Publication type:
- Article
3
Elevated basal antibody-dependent cell-mediated cytotoxicity (ADCC) and high epidermal growth factor receptor (EGFR) expression predict favourable outcome in patients with locally advanced head and neck cancer treated with cetuximab and radiotherapy.
- Published in:
- Cancer Immunology, Immunotherapy, 2017, v. 66, n. 5, p. 573, doi. 10.1007/s00262-017-1960-8
- By:
- Publication type:
- Article
4
Vedolizumab treatment for immune checkpoint inhibitor-induced enterocolitis.
- Published in:
- Cancer Immunology, Immunotherapy, 2017, v. 66, n. 5, p. 581, doi. 10.1007/s00262-017-1962-6
- By:
- Publication type:
- Article
5
Tumor specific regulatory T cells in the bone marrow of breast cancer patients selectively upregulate the emigration receptor S1P1.
- Published in:
- Cancer Immunology, Immunotherapy, 2017, v. 66, n. 5, p. 593, doi. 10.1007/s00262-017-1964-4
- By:
- Publication type:
- Article
6
Expression of VISTA correlated with immunosuppression and synergized with CD8 to predict survival in human oral squamous cell carcinoma.
- Published in:
- Cancer Immunology, Immunotherapy, 2017, v. 66, n. 5, p. 627, doi. 10.1007/s00262-017-1968-0
- By:
- Publication type:
- Article
7
Upregulation of thioredoxin-1 in activated human NK cells confers increased tolerance to oxidative stress.
- Published in:
- Cancer Immunology, Immunotherapy, 2017, v. 66, n. 5, p. 605, doi. 10.1007/s00262-017-1969-z
- By:
- Publication type:
- Article
8
Interleukin 21 inhibits cancer-mediated FOXP3 induction in naïve human CD4 T cells.
- Published in:
- Cancer Immunology, Immunotherapy, 2017, v. 66, n. 5, p. 637, doi. 10.1007/s00262-017-1970-6
- By:
- Publication type:
- Article
9
Evolution of MHC-based technologies used for detection of antigen-responsive T cells.
- Published in:
- Cancer Immunology, Immunotherapy, 2017, v. 66, n. 5, p. 657, doi. 10.1007/s00262-017-1971-5
- By:
- Publication type:
- Article
10
FOXO3, estrogen receptor alpha, and androgen receptor impact tumor growth rate and infiltration of dendritic cell subsets differentially between male and female mice.
- Published in:
- Cancer Immunology, Immunotherapy, 2017, v. 66, n. 5, p. 615, doi. 10.1007/s00262-017-1972-4
- By:
- Publication type:
- Article
11
Mechanisms of efficacy in cancer immunotherapy: 14th Annual Meeting of the Association for Cancer Immunotherapy (CIMT), Mainz, Germany, May 10-12, 2016.
- Published in:
- 2017
- By:
- Publication type:
- Report
12
Exercise and cancer: from 'healthy' to 'therapeutic'?
- Published in:
- Cancer Immunology, Immunotherapy, 2017, v. 66, n. 5, p. 667, doi. 10.1007/s00262-017-1985-z
- By:
- Publication type:
- Article
13
Intralesional treatment of metastatic melanoma: a review of therapeutic options.
- Published in:
- Cancer Immunology, Immunotherapy, 2017, v. 66, n. 5, p. 647, doi. 10.1007/s00262-016-1952-0
- By:
- Publication type:
- Article